Cost-effectiveness of imatinib versus interferon-alpha in the treatment of patients newly diagnosed with chronic myeloid leukemia, under the Brazilian public healthcare system perspective.

Mataveli, Fabio; Calabro, Alessandra; Mendes, Wellington; Vianna, Denizar; Dorlhiac-Llacer, Pedro; Bigni, Ricardo; Hungria, Vania

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/36287

Title:

Cost-effectiveness of imatinib versus interferon-alpha in the treatment of patients newly diagnosed with chronic myeloid leukemia, under the Brazilian public healthcare system perspective.

Author(s):

Institution:

Universidade Federal de São Paulo (UNIFESP)
Novartis Biociencias S A
Universidade Federal do Rio de Janeiro (UFRJ)
Universidade Estadual Paulista (UNESP)
Natl Canc Inst
San Casa São Paulo

ISSN:

0006-4971

Issue Date:

16-Nov-2006

Citation:

Blood. Washington: Amer Soc Hematology, v. 108, n. 11, p. 946A-946A, 2006.

Time Duration:

946A-946A

Publisher:

Amer Soc Hematology

Source:

http://abstracts.hematologylibrary.org/cgi/content/abstract/108/11/3314

URI:

Access Rights:

Acesso restrito

Type:

outro

Source:

http://repositorio.unesp.br/handle/11449/36287

Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.

Show full item record View Statistics